Actively Recruiting
Opportunity for Breast Cancer Patients to Meet With a Pathologist to Review Their Breast Sample Slides
Led by Dartmouth-Hitchcock Medical Center · Updated on 2025-07-22
20
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are exploring the experience of breast cancer patients meeting directly with pathologists to review their pathology slides. This study aims to understand if such encounters help patients feel more informed and empowered about their disease, and also whether these meetings are practical and beneficial for pathologists. This research addresses a relatively new approach since most pathologists typically have little direct patient contact. Participants will meet with a pathologist who will review their breast tissue slides and discuss disease characteristics. The study includes questionnaires to assess patients' understanding and feelings of control over their condition, as well as their overall knowledge of breast cancer pathology. These assessments will be conducted before and after the meeting to measure any changes. During the study, participants will complete knowledge questionnaires and surveys related to their disease and anxiety levels. The primary measure is how well patients understand and feel empowered about their condition after the pathologist visit. Secondary measures include knowledge about their personal disease details and general breast cancer pathology. The study monitoring lasts 1 to 2 weeks following the visit, with no long-term treatment or interventions involved.
CONDITIONS
Brief Title
24GUT540 : Meeting of Breast Cancer Patients and Pathologists
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Must be at least 18 years of age.
- Patients must have completed initial diagnosis visit with oncologist or surgeon.
- Must have pathology slides and reports available for review.
- Must be able to speak English.
- Must be willing to participate in this research and will be provided with an information sheet.
- Pregnant women are eligible as this research poses no risk of physical harm to the participant.
You will not qualify if you...
- Patients under 18 years of age.
- Patients with ductal carcinoma in situ (DCIS) are ineligible.
- Adults who are unable to provide written signature.
- Patients from vulnerable populations, including infants, minors, those unable to provide informed consent, and those incarcerated or imprisoned at enrollment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 to 2 weeks
Participants complete questionnaires to assess their understanding of and sense of control regarding their disease, including their perceptions of the benefit of meeting with a pathologist.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756
Actively Recruiting
Research Team
R
Research Nurse
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here